1
|
Al-Monajjed R, Albers P, Droop J, Fugmann D, Noldus J, Palisaar RJ, Ritter M, Ellinger J, Krausewitz P, Truß M, Hadaschik B, Grünwald V, Schrader AJ, Papavassilis P, Ernstmann N, Schellenberger B, Moritz A, Kowalski C, Hellmich M, Heiden P, Hagemeier A, Horenkamp-Sonntag D, Giessing M, Pauler L, Dieng S, Peters M, Feick G, Karger A. PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial. Trials 2024; 25:754. [PMID: 39533412 PMCID: PMC11556073 DOI: 10.1186/s13063-024-08579-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2024] [Accepted: 10/24/2024] [Indexed: 11/16/2024] Open
Abstract
BACKGROUND With over 65,000 new cases per year in Germany, prostate cancer (PC) is the most common cancer in men in Germany. Localized PC is often treated by radical prostatectomy and has a very good prognosis. Postoperative quality of life (QoL) is significantly influenced by the side effects of surgery. One possible approach to improve QoL is postoperative symptom monitoring using ePROMs (electronic patient-reported outcome measures) to accurately identify any need for support. METHODS The PRO-P ("Influence of ePROMS in surgical therapy of PC on the postoperative course") study is a randomized controlled trial employing 1:1 randomization at 6 weeks postoperatively, involving 260 patients with incontinence (≥ 1 pad/day) at six participating centers. Recruitment is planned for 1 year with subsequent 1-year follow-up. PRO-monitoring using domains of EPIC-26, psychological burden, and QoL are assessed 6, 12, 18, 24, 36, and 52 weeks postoperatively. Exceeding predefined PRO-score cutoffs triggers an alert at the center, prompting patient contact, medical consultation, and potential interventions. The primary endpoint is urinary continence. Secondary endpoints refer to EPIC-26 domains, psychological distress, and QoL. Aspects of feasibility, effect, and implementation of the intervention will be investigated within the framework of a qualitative process evaluation. DISCUSSION PRO-P investigates the effect on postoperative symptom monitoring of a structured follow-up using ePROMs in the first year after prostatectomy. It is one of the first studies in cancer surgery investigating PRO-monitoring and its putative applicability to routine care. Patient experiences with intensified monitoring of postoperative symptoms and reflective counseling will be examined in order to improve primarily urinary continence, and secondly other burdens of physical and psychological symptoms, quality-of-life, and patient competence. The potential applicability of the intervention in clinical practice is facilitated by IT adaption to the certification standards of the German Cancer Society and the integration of the ePROMs survey via a joint patient portal. Positive outcomes could readily translate this complex intervention into routine clinical care. PRO-P might improve urinary incontinence and QoL in patients with radical prostatectomy through the structured use of ePROMs. TRIAL REGISTRATION ClinicalTrials.gov NCT05644821. Registered on 09 December 2022.
Collapse
Affiliation(s)
- Rouvier Al-Monajjed
- Department of Urology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Düsseldorf, Germany
| | - Peter Albers
- Department of Urology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Düsseldorf, Germany
- Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Johanna Droop
- Department of Urology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Düsseldorf, Germany
| | - Dominik Fugmann
- Clinical Institute for Psychosomatic Medicine and Psychotherapy, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Düsseldorf, Germany.
| | - Joachim Noldus
- Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Bochum, Germany
| | - Rein-Jüri Palisaar
- Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Bochum, Germany
| | - Manuel Ritter
- Department of Adult and Pediatric Urology, University Hospital Bonn, Bonn, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Bonn, Germany
| | - Jörg Ellinger
- Department of Adult and Pediatric Urology, University Hospital Bonn, Bonn, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Bonn, Germany
| | - Philipp Krausewitz
- Department of Adult and Pediatric Urology, University Hospital Bonn, Bonn, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Bonn, Germany
| | - Michael Truß
- Department of Urology, Klinikum Dortmund, Dortmund, Germany
| | - Boris Hadaschik
- Department of Urology, University Hospital Essen, Essen, Germany
| | - Viktor Grünwald
- Department of Urology, University Hospital Essen, Essen, Germany
- Department for Medical Oncology, University Hospital Essen, Essen, Germany
| | - Andres-Jan Schrader
- Department of Adult and Pediatric Urology, University Hospital Münster, Münster, Germany
| | - Philipp Papavassilis
- Department of Adult and Pediatric Urology, University Hospital Münster, Münster, Germany
| | - Nicole Ernstmann
- Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR), Chair of Health Services Research, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - Barbara Schellenberger
- Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR), Chair of Health Services Research, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - Anna Moritz
- Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR), Chair of Health Services Research, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - Christoph Kowalski
- Department of Certification - Health Services Research, German Cancer Society, Berlin, Germany
| | - Martin Hellmich
- Institute of Medical Statistics and Computational Biology (IMSB), Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - Pierce Heiden
- Institute of Medical Statistics and Computational Biology (IMSB), Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - Anna Hagemeier
- Institute of Medical Statistics and Computational Biology (IMSB), Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | | | - Markus Giessing
- Department of Urology, Kliniken Maria Hilf, Mönchengladbach, Germany
| | | | | | | | - Günter Feick
- Federal Prostate Cancer Self-Help, BPS, Bonn, Germany
| | - André Karger
- Clinical Institute for Psychosomatic Medicine and Psychotherapy, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany and Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf (CIO-ABCD, Germany), Düsseldorf, Germany
| |
Collapse
|
2
|
Calvo-Schimmel A, Newman SD, Sterba KR, Miaskowski C, Qanungo S. Barriers and Facilitators to Supportive Care Implementation in Advanced Disease Prostate Cancer Survivors: A Theory-Informed Scoping Review. Cancer Nurs 2022; 45:E782-E800. [PMID: 35025769 DOI: 10.1097/ncc.0000000000001051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Individualized supportive care is recommended to manage the debilitating effects of advanced prostate cancer and its treatments. Yet, the implementation of supportive care in practice remains inconsistent. OBJECTIVE The aim of this study was to synthesize the barriers and facilitators to implementing supportive care interventions after identifying supportive care interventions for advanced prostate cancer survivors. METHODS PubMed, SCOPUS, CINAHL Complete, ProQuest, and PsycINFO were searched for relevant studies published between 2011 and 2020. Studies were included if they reported on a supportive care intervention and included a description of implementation barriers and/or facilitators. The Theoretical Domains Framework was used to characterize implementation barriers and facilitators. RESULTS Of the 620 articles identified, 13 met all prespecified inclusion criteria. Primary barriers were related to the domains of environmental context and resources (eg, limited resources), knowledge (eg, insufficient knowledge on efficacy of supportive care), and beliefs about capabilities (eg, lack of confidence in materials). Facilitators fell under environmental context and resources (partnerships with local services), reinforcement (eg, partners inclusion), and skills (eg, delivery by professionals). CONCLUSIONS This scoping review highlights barriers and facilitators that affect supportive care implementation. Future research that focuses on overcoming barriers and maximizing facilitators is needed to improve, modify, or supplement existing supportive care implementation practices. IMPLICATIONS FOR PRACTICE As the number of advanced prostate cancer survivors continues to increase, supportive care must become the standard of care. Future interventions must incorporate increased knowledge and funding, alternative delivery models, and consistent use of specialty nurses.
Collapse
Affiliation(s)
- Alejandra Calvo-Schimmel
- Author Affiliations: College of Nursing (Dr Calvo-Schimmel), Department of Nursing Operating (Drs Qanungo and Newman); and Department of Public Health Sciences (Dr Sterba), Medical University of South Carolina, Charleston; and Department of Physiological Nursing, School of Nursing, University of California, San Francisco (Dr Miaskowski)
| | | | | | | | | |
Collapse
|
4
|
Bamidele OO, Alexis O, Ogunsanya M, Greenley S, Worsley A, Mitchell ED. Barriers and facilitators to accessing and utilising post-treatment psychosocial support by Black men treated for prostate cancer-a systematic review and qualitative synthesis. Support Care Cancer 2022; 30:3665-3690. [PMID: 34982226 PMCID: PMC8724231 DOI: 10.1007/s00520-021-06716-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2021] [Accepted: 11/19/2021] [Indexed: 11/26/2022]
Abstract
PURPOSE To synthesise findings from published studies on barriers and facilitators to Black men accessing and utilising post-treatment psychosocial support after prostate cancer (CaP) treatment. METHODS Searches of Medline, Embase, PsycInfo, Cochrane Database of Systematic Reviews and Central, CINAHL plus and Scopus were undertaken from inception to May 2021. English language studies involving Black men aged ≥18 and reporting experiences of, or suggestions for, psychosocial support after CaP treatment were included. Low or moderate quality studies were excluded. Searches identified 4,453 articles and following deduplication, 2,325 were screened for eligibility. Two independent reviewers carried out screening, quality appraisal and data extraction. Data were analysed using thematic synthesis. RESULTS Ten qualitative studies involving 139 Black men were included. Data analysis identified four analytical constructs: experience of psychosocial support for dealing with treatment side effects (including impact on self-esteem and fear of recurrence); barriers to use of psychosocial support (such as perceptions of masculinity and stigma around sexual dysfunction); facilitators to use of psychosocial support (including the influence of others and self-motivation); and practical solutions for designing and delivering post-treatment psychosocial support (the need for trusted healthcare and cultural channels). CONCLUSIONS Few intervention studies have focused on behaviours among Black CaP survivors, with existing research predominantly involving Caucasian men. There is a need for a collaborative approach to CaP care that recognises not only medical expertise but also the autonomy of Black men as experts of their illness experience, and the influence of cultural and social networks.
Collapse
Affiliation(s)
- Olufikayo O. Bamidele
- Institute for Clinical and Applied Health Research, Hull York Medical School, University of Hull, Hull, HU6 7RX UK
| | - Obrey Alexis
- Faculty of Health and Life Sciences, Oxford Brookes University, Joel Joffe Building, Delta 900, Welton Way, Swindon, SN5 7XQ UK
| | - Motolani Ogunsanya
- Department of Pharmacy, Clinical & Administrative Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, OK USA
| | - Sarah Greenley
- Cancer Research Group, Hull York Medical School, University of Hull, Hull, HU6 7RX UK
| | - Aaron Worsley
- Directorate of Learning Resources, Oxford Brookes University, Oxford, OX3 OBP UK
| | | |
Collapse
|
5
|
Paterson C, Primeau C, Howard N, Xiberras P, Pillay B, Crowe H. Experiences of Unmet Need and Access to Supportive Care for Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Bi-national Study. Semin Oncol Nurs 2020; 36:151049. [PMID: 32703715 DOI: 10.1016/j.soncn.2020.151049] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE The number of men affected by incurable prostate cancer is expected to increase worldwide. Research is needed to enable men to share their experiences of unmet supportive care needs in current care delivery. We aimed to identify the most frequently reported domains of unmet supportive care needs, levels of anxiety, depression, distress, health-related quality of life, and to identify any perceived barriers to receiving supportive care. DATA SOURCES Men diagnosed with prostate cancer who had received a minimum of 6 months of ADT were recruited into a cross-sectional study. Participants completed standardised questionnaires; clinical and demographic data was also collected. CONCLUSION Two hundred seventy-two patients were invited, and 102 participated. No statistically significant differences were found between participant scores from Australia and UK in relation to anxiety and depression, exercise, health-related quality of life, or distress scores. Perceived barriers include service delivery related to information provision and difficulties in the navigation of complex care systems. IMPLICATIONS FOR NURSING PRACTICE Men affected by prostate cancer receiving ADT reported unmet supportive care needs, specifically related to sexual, informational, and psychological aspects of care. Mapping future trajectories of needs and identifying men at high risk can significantly improve timely and tailored interventions.
Collapse
Affiliation(s)
- Catherine Paterson
- Faculty of Health, University of Canberra, Canberra ACT, Australia; Robert Gordon University, Aberdeen, Garthdee, Scotland; Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research group, University of Canberra, Canberra ACT, Australia; ACT Synergy Nursing and Midwifery Research Centre, Canberra Hospital and ACT Health, ACT, Australia.
| | | | | | | | - Brindha Pillay
- Epworth HealthCare, Victoria, Australia; Peter MacCallum Cancer Centre, Victoria, Australia; Royal Melbourne Hospital, Victoria, Australia
| | - Helen Crowe
- Epworth HealthCare, Victoria, Australia; Australian Prostate Centre, Victoria, Australia; Royal Melbourne Hospital, Victoria, Australia
| |
Collapse
|